Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/08/2009US7629383 Double esters
12/08/2009US7629382 neuroprotectants is used for the treatment and prevention of neurodegenerative disorders, Parkinson's disease; ammonium trichloro(dioxyethylene-O,O')tellurate
12/08/2009US7629381 Such as picropodophyllin, for the inhibition of the insulin-like growth factor-1 receptor; cancer, psoriasis, artherosclerosis and acromegaly
12/08/2009US7629380 Antitumor agents
12/08/2009US7629379 Substituted phosphonate fluorescent sensors and use thereof
12/08/2009US7629378 Antiallergens; analgesics; using doxepin, or isomer thereof; side effect reduction
12/08/2009US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
12/08/2009US7629376 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I
12/08/2009US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009US7629374 Use of aminoindazole derivatives for the inhibition of tau phosphorylation
12/08/2009US7629373 Mitotic kinesin inhibitors
12/08/2009US7629372 Compounds for the treatment of dyslipidemia and other lipid disorders
12/08/2009US7629371 Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite
12/08/2009US7629370 3-phenylpropionic acid derivatives
12/08/2009US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
12/08/2009US7629368 Nitroderivatives as drugs for diseases having an inflammatory basis
12/08/2009US7629367 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example
12/08/2009US7629366 Aminoalcohol derivatives
12/08/2009US7629365 Heterocyclic compounds
12/08/2009US7629364 Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
12/08/2009US7629363 Diaryl substituted pyridinones
12/08/2009US7629362 2-pyridine carboxamide derivatives
12/08/2009US7629361 Salt of (S)-pantoprazole and its hydrates
12/08/2009US7629360 reducing the levels of tumor necrosis factors by administering a drug comprising1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
12/08/2009US7629359 Use of piperidine derivatives as dermo-decontracting agents
12/08/2009US7629358 For therapy of inflammatory, allergic and respiratory diseases
12/08/2009US7629357 Antihypoxic agents; adjust concentration of erythropoietin concentration in blood; strokes; antiepileptic agents; neurodegenerative disease ; liver disorders; antiischemic agents
12/08/2009US7629355 Use of e.g. N-[(1R,S)-1-Cyclopropylethyl]-Normorphine for treating opiate, cocaine, or alcohol addiction
12/08/2009US7629354 Use of phanquinone for the treatment of Alzheimer's disease
12/08/2009US7629353 Vasopressin (V1a) receptor; dysmenorrhea, hypertension, chronic heart failure, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder, anxiety and depressive disorders; 1'-[(1-benzyl-2-methyl-1H-indol-3-yl)carbonyl]spiro[indene-1,4'-piperidine] one for example
12/08/2009US7629352 Pharmaceutical composition comprising a corticosteroid and a specific inhibitor of hedgehog/smoothened signaling
12/08/2009US7629351 antiinflammatory agent, anticarcinogenic agent; for treating inflammatory diseases, allergic, autoimmune, metabolic, cancer, cardiovascular diseases
12/08/2009US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009US7629349 Parkinson's disease; antidepressants; cognition activators; analgesics; brain disorders; drug combination
12/08/2009US7629348 Insecticides; for human or veterinary medicine
12/08/2009US7629347 Modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; cancer; chronic myelogic leukemia
12/08/2009US7629346 Pyrazinecarboxamide derivatives as CB1 antagonists
12/08/2009US7629345 Improved pharmacological activity and tolerability; glaucoma; ocular hypertension
12/08/2009US7629344 3-(imidazolyl)-pyrazolo[3,4-b]pyridines
12/08/2009US7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
12/08/2009US7629342 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
12/08/2009US7629341 Human ADAM-10 inhibitors
12/08/2009US7629340 N-(6-membered aromatic ring)-amido anti-viral compounds
12/08/2009US7629339 inhibitors of protein kinases and are useful in treating cancer; 4-({5-[5-Fluoro-2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carbonyl}-amino)-3-methoxy-butyric acid; anticarcinogenic agent
12/08/2009US7629338 for treating migraine, headaches; N-[(4S)-3-Methyl-2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-inden]-5'-yl]-2-((6+-)-2-oxo-6-phenylpiperidin-1-yl)acetamide
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009US7629336 Biphenyl compounds useful as muscarinic receptor antagonists
12/08/2009US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
12/08/2009US7629334 Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
12/08/2009US7629333 administering sterile, room temp. stable amorphous amifostine having specific weight % of degration product 2-[(3aminopropyl)amino]ethane thiol, with a vehicle into an injectable particulate-free drug product for reducing adverse effect of chemo or radiation therapy of cancer patient
12/08/2009US7629332 Antitumor agents such as 2-[(2-Bromoethyl)-2,4-dinitro-6-[[[2-(phosphonooxy)ethyl]amino]-carbonyl]anilino]ethyl methanesulfonate; killing hypoxic cells in a tumor
12/08/2009US7629331 Sulfoalkyl ether cyclodextrin; use in pharmaceutical dosage forms as solubilizer or stabilizer
12/08/2009US7629330 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/08/2009US7629329 Method for increasing muscle mass and strength through administration of adenosine triphosphate
12/08/2009US7629328 Use of 6-oxyamino-7-deazapurine-ribofuranose derivatives, e.g. 1-(6-hydroxylamino-7-ethynyl-7-deazapurin-9-yl)-2-methyl-beta-D-ribofuranose
12/08/2009US7629327 Chlamydia 60 Kda CRMP antigens and vaccine uses
12/08/2009US7629326 Chromosomal modification involving the induction of double-stranded DNA cleavage and homologous recombination at the cleavage site
12/08/2009US7629324 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/08/2009US7629322 carries capsid protein mutations resulting in a reduced heparin binding function, suitable for gene therapy by systemic application, since transduction of the liver is eliminated; gene therapy in a heart muscle tissue of a patient
12/08/2009US7629321 Oligoribonucleotides and ribonucleases for cleaving RNA
12/08/2009US7629320 Oxyamino-pyrazolo[3,4-d]pyrimidinylribofuranose derivatives, e.g., 1-(2'-C-methyl- beta -D-ribofuranosyl)-4-methoxylamino-pyrazolo[3,4-d]pyrimidine and 1-(2'-C-methyl- beta -D-ribofuranosyl)-3-cyano-4-methoxylamino-pyrazolo[3,4-d]pyrimidine
12/08/2009US7629313 Immunomodulatory polymeric antigens for treating inflammatory pathologies
12/08/2009US7629293 Activation of bamboo charcioal powderas with sodium alginate surfactant; reacting diaminedinitrate silver is reacted with hydrazine hydrate; forming silver on bamboo charcoal; stirring continuously under inert gas; separation, washing with water and ethanol,drying under vacuum
12/08/2009US7629155 foods and beverages containing 1,4-dihydroxy-2-naphthalene carboxylic acid or salts, used for improving intestinal flora, alleviating abdominal ailments caused by lactose intolerance and for preventing or treating metabolic bone diseases
12/08/2009US7629145 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders
12/08/2009US7629014 Defatted canola flake, protein, and phytate; isoelectric precipitation and/or ultrafiltration
12/08/2009US7629005 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/08/2009US7629003 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
12/08/2009US7629002 Antimicrobial polymeric compositions and method of treatment using them
12/08/2009US7628999 Personal care compositions
12/08/2009US7628998 Providing a natural appearance, healthy glow, and other aesthetic benefits to the skin. One composition has a shade-matched pearlescent component. Another composition has a blend of a shade-matched pearlescent component and a
12/08/2009US7628990 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
12/08/2009US7628989 Methods of inducing an immune response
12/08/2009US7628988 Induce cell differentiation; process control
12/08/2009US7628985 Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis
12/08/2009US7628984 Micronutrient formulations for pulmonary and heart health
12/08/2009US7628981 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/08/2009US7628978 Stabilized preparations for use in metered dose inhalers
12/08/2009US7628977 Particles for inhalation having sustained release properties
12/08/2009US7628851 Implants; flexibility, toughness; mixture of calcium compound and reinforcing fibers
12/08/2009CA2540858C Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
12/08/2009CA2522180C 2-azabicyclo[3.3.1]nonane derivatives as opioid receptor antagonists
12/08/2009CA2485916C Non-nucleoside reverse transcriptase inhibitors
12/08/2009CA2482311C Furyl compounds
12/08/2009CA2481994C Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
12/08/2009CA2452827C Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
12/08/2009CA2440744C Il-12 expression controlling agent
12/08/2009CA2434911C Use of l-carnitine as stabilizing agent of proteins
12/08/2009CA2434829C New benzoylguanidine salt
12/08/2009CA2424396C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
12/08/2009CA2422807C N-substituted benzothiophenesulfonamide derivatives
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009CA2419301C Quinazoline derivatives
12/08/2009CA2416480C Method for the treatment of climacteric disorders in women during or after the menopause
12/08/2009CA2415486C Pyramidine derivatives
12/08/2009CA2404725C Extrusion die
12/08/2009CA2404005C Composition comprising free amino acids
12/08/2009CA2400371C Methods to prepare micelles comprising amphiphilic lipopolysaccharide compounds
12/08/2009CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
1 ... 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 ... 7860